Social networks
1,549 5,020Activities
Technologies
Entity types
Location
399 Bradford St #101, Redwood City, CA 94063, USA
Redwood City
United States of America
Employees
Scale: 11-50
Estimated: 37
Engaged corporates
9Added in Motherbase
4 years, 8 months agoWe partner with healthcare providers and payers to optimize cognitive screening workflows with efficient digital tools.
Cognitive health starts here. Neurotrack’s rapid digital cognitive screening can identify patients with cognitive impairment in just 3 minutes. This tool enables clinicians—for the first time ever—to screen and monitor cognitive function as they would any other vital sign. We believe it will increase the number of annual cognitive assessments completed, open the door to meaningful early intervention, improve access to new pharmaceutical treatment options, and validate or alleviate patient concerns. By design, it fits easily within a typical primary care annual wellness visit workflow. It scores instantly and objectively, requires no specialized training to administer, and uses culturally-agnostic symbols and numbers to ensure inclusivity and remove barriers to care.
In 40 seconds, a medical assistant can set a patient up to take the screening on a tablet independently in an exam room, then upload results to the EMR. Or patients can be sent a link to take the test remotely and walk in ready to discuss results.
As a complement to this first-line screening, Neurotrack offers access to patient education and coaching to support a brain-healthy lifestyle.
Neurotrack has published 25 peer-reviewed papers and its solutions have been recognized by leading organizations including the Cleveland Clinic and the National Institute on Aging. Working with providers, health systems and employer partners, Neurotrack has enabled more than 170,000 cognitive assessments on its platform.
In February 2023, Neurotrack was named winner of the Alzheimer’s Association Pitch Competition, aimed at identifying innovations to increase cognitive assessment and early detection and diagnosis of dementia within primary care settings. In August 2023, we were named to the Norrsken Impact/100, a list of the world's top impact startups.
The company has raised a total of $57 million in funding to support and accelerate its go-to-market push with major health systems and providers.
See why health systems choose our clinically validated, FDA class II device for in office and remote cognitive screening.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Eisai Co., Ltd. Pharmaceutical | Eisai Co., Ltd. Pharmaceutical | Other 28 Oct 2023 | | |
Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 28 Oct 2023 | | |
Prime Time Healthcare Startup accelerator & VC, Publishing, Hospitals and Health Care | Prime Time Healthcare Startup accelerator & VC, Publishing, Hospitals and Health Care | Other 26 Oct 2023 | | |
NeuroTechX Biotechnology, Biotechnology Research | NeuroTechX Biotechnology, Biotechnology Research | Other 13 Sep 2023 | | |
Plug and Play Tech Center Startup accelerator & VC, Venture Capital and Private Equity Principals | Plug and Play Tech Center Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 14 Jun 2019 | | |
General Electric Building supplies, Industrial Machinery Manufacturing | General Electric Building supplies, Industrial Machinery Manufacturing | Other 17 Jun 2019 | | |
Biogen Biotechnology, Biotechnology Research | Biogen Biotechnology, Biotechnology Research | Other 20 Mar 2015 28 Oct 2023 | | |
Google IT services, Software Development | Google IT services, Software Development | Not capitalistic Partnership Not event 28 Jan 2015 | | |
ITC Europe Insurance, Events Services | ITC Europe Insurance, Events Services | Not capitalistic Not partnership Event 5 Feb 2019 | |